(Reuters) -Illumina CEO Francis deSouza stepped down on Sunday, marking a victory for activist investor Carl Icahn and heightening expectations that it could unwind its controversial $7.1 billion acqu[...]
Read more
June 12, 2023
American, JetBlue urge US judge to allow them to keep codeshare arrangements
By David Shepardson WASHINGTON (Reuters) – American Airlines and JetBlue Airways asked a U.S. judge late Friday to allow them to continue mutual frequent flyer recognition and codeshare arrangem[...]
Read more
US Supreme Court’s dog toy ruling puts parody products on notice
By Blake Brittain (Reuters) – The U.S. Supreme Court handed brand owners a win against parody products on Thursday when it ruled that “Bad Spaniels” dog toys resembling Jack Daniel[...]
Read more
Verizon searching for new finance chief and potential CEO successor – WSJ
(Reuters) – Verizon Communications is searching for a new finance chief and looking for potential candidates to later succeed CEO Hans Vestberg, the Wall Street Journal reported on Monday citing[...]
Read more
Explainer-How France secured a fall in food prices
By Sybille de La Hamaide PARIS (Reuters) – French Finance Minister Bruno Le Maire said last week he had secured a pledge from 75 top food companies to cut prices on hundreds of products next mon[...]
Read more
NY Fed finds Americans see lower inflation level a year from now
By Michael S. Derby NEW YORK (Reuters) – Americans’ expectations for inflation a year from now fell to the lowest level in two years, even as those same households said they expected more challe[...]
Read more
Glencore makes offer for Teck’s steelmaking coal business
By Clara Denina LONDON (Reuters) -Glencore on Monday offered to buy Teck Resources’ steelmaking coal business as a standalone unit, after the Canadian miner twice rebuffed its $22.5 billon offer[...]
Read more
Thyssenkrupp pulls trigger on long-awaited IPO of hydrogen division Nucera
By Christoph Steitz and Tom Käckenhoff FRANKFURT/DUESSELDORF (Reuters) -Thyssenkrupp launched on Monday the long-awaited listing of its hydrogen division Nucera, suggesting its new chief executive int[...]
Read more
Biogen rises as FDA panel backs Alzheimer’s drug, easing safety concerns
(Reuters) – Biogen’s shares rose 2% on Monday as a unanimous backing of its Alzheimer’s drug by the U.S. health regulator’s advisers strengthened the case for a traditional app[...]
Read more